Liana Chan

Title: Liana Chan: Innovator in Macrophage Therapeutics

Introduction

Liana Chan is a prominent inventor based in San Pedro, CA (US). She has made significant contributions to the field of biomedical innovation, particularly in the area of macrophage therapeutics. Her work focuses on the priming of macrophage cells for therapeutic applications, which has the potential to revolutionize treatment methods for infections and tumors.

Latest Patents

Liana Chan holds a patent titled "Target-primed macrophages and therapeutic uses thereof." This patent encompasses cell populations, compositions, and methods related to the target priming of macrophage cells. The macrophages, once primed or activated with a microorganism, can be utilized to prevent or treat infections caused by that microorganism. Additionally, when activated by tumor cells or tumor antigens, these macrophages can be employed to prevent or treat tumors of the same kind. The priming process can be conducted in vitro or ex vivo, and the macrophages can be isolated from the subject undergoing disease prevention or treatment. She has 1 patent to her name.

Career Highlights

Liana Chan is affiliated with The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. Her role at this esteemed institution allows her to collaborate with leading experts in the field and contribute to groundbreaking research in macrophage biology and therapeutics.

Collaborations

Liana has worked alongside notable colleagues such as Scott G. Filler and Michael R. Yeaman. Their collaborative efforts have further advanced the understanding and application of macrophage-targeted therapies.

Conclusion

Liana Chan's innovative work in macrophage therapeutics highlights her commitment to advancing medical science. Her contributions have the potential to significantly impact the treatment of infections and tumors, showcasing the importance of innovation in healthcare.